Promising New PD Fluid
In a Phase 2 study, PD-protec® from Zytoprotec in Vienna, Austria, reduced the risk of peritonitis and of membrane failure. The new fluid was well-tolerated, with no adverse events. Once on the market, this fluid could improve PD outcomes and allow more people to stay longer on the therapy.
Read the full article » | Posted 07-14-2017
Related Articles
- Drexel University and Partners Produce a Portable Wearable Dialysis System Posted 05-14-2021
- OpticLine Receives KidneyX Award for a Device to Detect Peritonitis Posted 05-14-2021
- New, 2-lb. WAK 3.0 Receives Patent Posted 03-09-2021
- KidneyX Winners Claim Backpack Kidney Is 18 Months Away Posted 02-09-2021